|
MTAP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.273200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.148600E-01 |
| Normal-vs-Stage2 |
8.805200E-01 |
| Normal-vs-Stage3 |
3.426200E-01 |
| Normal-vs-Stage4 |
2.711600E-01 |
| Stage1-vs-Stage2 |
5.179400E-01 |
| Stage1-vs-Stage3 |
1.761230E-01 |
| Stage1-vs-Stage4 |
3.928600E-01 |
| Stage2-vs-Stage3 |
5.386400E-01 |
| Stage2-vs-Stage4 |
2.904400E-01 |
| Stage3-vs-Stage4 |
1.741400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.517600E-01 |
| Normal-vs-AfricanAmerican |
3.952400E-01 |
| Normal-vs-Asian |
5.740400E-01 |
| Caucasian-vs-AfricanAmerican |
5.561200E-01 |
| Caucasian-vs-Asian |
6.609200E-01 |
| AfricanAmerican-vs-Asian |
7.987000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.857200E-01 |
| Normal-vs-Female |
4.380400E-01 |
| Male-vs-Female |
1.697800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.495800E-01 |
| Normal-vs-Extreme_Weight |
1.280630E-01 |
| Normal-vs-Obese |
4.329800E-01 |
| Normal-vs-Extreme_Obese |
4.939800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.217200E-01 |
| Normal_Weight-vs-Obese |
1.683830E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.001400E-01 |
| Extreme_Weight-vs-Obese |
6.223700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.194800E-01 |
| Obese-vs-Extreme_Obese |
3.390600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.358180E-01 |
| Normal-vs-Age(41-60Yrs) |
4.070800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.596350E-01 |
| Normal-vs-Age(81-100Yrs) |
6.086300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.545550E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.317810E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.898160E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.939700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.055500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.482400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.210400E-01 |
| Normal-VS-Type2 PRCC |
2.871800E-02 |
| Normal-VS-KIRP CIMP |
2.364100E-03 |
| Normal-VS-Unclassified PRCC |
8.941400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.869840E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.29480000002447E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
7.867200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.6479999545096E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
1.565770E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.43479999999519E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.034500E-02 |
| Normal-vs-N1 |
6.895400E-01 |
| Normal-vs-N2 |
9.090800E-01 |
| N0-vs-N1 |
1.065840E-01 |
| N0-vs-N2 |
5.510400E-01 |
| N1-vs-N2 |
8.363600E-01 |
|
|
